← All stocks

Arcturus Therapeutics Holdings Inc.

ARCT Net selling

CIK 0001768224 #3570 in the set updated 18 Sep 2026

Bought (120 mo)

$787.85K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$138.48M

$4.92M on a plan · $440.24K straight out of an exercise

Sold at will

$133.12M

21 of 39 sales

Net

−$137.69M

−$132.33M against sales at will

By person

11 insiders · 54 transactions

32.6×

Joseph E. Payne holds 32.6 times base salary in stock. $24.51M of shares against $750.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph E. Payne last reported holding, valued at $16.56, the price Common Stock was last bought or sold at on the open market here, on 15 Aug 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ultragenyx Pharmaceutical Inc. entity

Director

—

$124.28M (4)

−$124.28M

1,400,000

4.93%

$23.18M

−41.7%

Chivukula Pad

Chief Scientific Officer & COO

—

$12.16M (32)

−$12.16M

435,334

1.53%

$7.21M

−40.6%

SASSINE ANDY

Chief Financial Officer

$433.16K (5)

$1.60M (1)

−$1.17M

221,764

0.7802%

$3.67M

−7.6%

Kummerfeld Keith C

See Remarks

$20.35K (2)

$440.24K (2) scheduled

−$419.89K

950

0.0033%

$15.73K

—

Payne Joseph E

President and CEO

$170.34K (3)

—

+$170.34K

1,480,097

5.21%

$24.51M

+0.7%

FARRELL PETER C

Director

$99.67K (2)

—

+$99.67K

98,696

0.3472%

$1.63M

+14.2%

Marquet Magda

Director

$64.33K (2)

—

+$64.33K

50,793

0.1787%

$841.03K

+17.7%

BARLOW JAMES F

Director

—

13,131

0.0462%

$217.42K

+31.3%

Markels John

Director

—

3,131

0.0110%

$51.84K

—

Marantz Jing L.

Director

—

3,131

0.0110%

$51.84K

—

HOLMES EDWARD W

Director

—

3,131

0.0110%

$51.84K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

SASSINE ANDY

12 Jun 2024

Chief Financial Officer

Sell

50,000

$32.03

$1.60M

Chivukula Pad

6 Mar 2023

Chief Scientific Officer & COO

Sell

5,000

$16.07

$80.35K

Chivukula Pad

4 Jan 2022

Chief Scientific Officer & COO

Sell

8,100

$40.00

$324.00K

Chivukula Pad

16 Dec 2021

Chief Scientific Officer & COO

Sell

3,633

$40.00

$145.33K

Chivukula Pad

8 Dec 2021

Chief Scientific Officer & COO

Sell

6,367

$40.00

$254.68K

Chivukula Pad

1 Nov 2021

Chief Scientific Officer & COO

Sell

10,000

$44.41

$444.10K

Chivukula Pad

1 Oct 2021

Chief Scientific Officer & COO

Sell

10,000

$44.36

$443.60K

Chivukula Pad

1 Sep 2021

Chief Scientific Officer & COO

Sell

10,000

$55.86

$558.60K

Ultragenyx Pharmaceutical Inc.

11 Aug 2021

Director

Sell

75,000

$45.83

$3.44M

Ultragenyx Pharmaceutical Inc.

10 Aug 2021

Director

Sell

725,000

$55.44

$40.19M

Chivukula Pad

3 Aug 2021

Chief Scientific Officer & COO

Sell

10,000

$40.07

$400.70K

Chivukula Pad

1 Apr 2021

Chief Scientific Officer & COO

Sell

10,000

$42.95

$429.50K

Chivukula Pad

1 Mar 2021

Chief Scientific Officer & COO

Sell

10,000

$54.23

$542.30K

Chivukula Pad

1 Feb 2021

Chief Scientific Officer & COO

Sell

10,000

$75.31

$753.10K

Chivukula Pad

4 Jan 2021

Chief Scientific Officer & COO

Sell

10,000

$46.40

$464.00K

Ultragenyx Pharmaceutical Inc.

9 Dec 2020

Director

Sell

357,745

$94.97

$33.98M

Ultragenyx Pharmaceutical Inc.

8 Dec 2020

Director

Sell

442,255

$105.54

$46.68M

Chivukula Pad

1 Dec 2020

Chief Scientific Officer & COO

Sell

10,000

$96.19

$961.90K

Chivukula Pad

2 Nov 2020

Chief Scientific Officer & COO

Sell

10,000

$55.28

$552.80K

Chivukula Pad

1 Oct 2020

Chief Scientific Officer & COO

Sell

10,000

$42.83

$428.30K

Chivukula Pad

3 Sep 2020

Chief Scientific Officer & COO

Sell

10,000

$45.16

$451.60K

Show all 54 transactions →

Arcturus Therapeutics Holdings Inc.

By person

Individual transactions

What was left out